Venmax Drugs and Pharmaceuticals Limited announced unaudited earnings results for the first quarter ended June 30, 2018. For the quarter, the company reported loss before exceptional items and tax and loss before tax was INR 0.185 million compared with INR 0.168 million for the same period a year ago. Net loss was INR 0.185 million or INR 0.04 per basic and diluted share compared with INR 0.168 million or INR 0.03 per basic and diluted share for the same period a year ago.